Medicine News and Research

RSS

American endocrinologists aim to keep patients safe

As medicine becomes more complex and patients live longer and better lives, it also becomes more difficult to keep them safe.

17 Jan 2005

Damp and mould in homes causes asthma

Researchers at the University of Birmingham's Institute for Occupational and Environmental Medicine are citing damp and mould in homes as a cause of asthma. The study is published in the Environmental Health Perspectives journal and links the University of Birmingham with the University of Helsinki, Finland and the Diwan College, Taiwan.

17 Jan 2005

Anti-seizure drugs slow aging in roundworms

Researchers at Washington University School of Medicine in St. Louis have discovered that a class of anti-seizure medications slows the rate of aging in roundworms. The worms, when exposed to drugs used to treat epilepsy in humans, lived longer and retained youthful functions longer than normal.

17 Jan 2005

Researchers have identified the cellular receptor for the JC virus

Researchers funded in part by the National Institute of Neurological Disorders and Stroke (NINDS) have identified the cellular receptor for the JC virus, which causes the fatal neurological disease progressive multifocal leukoencephalopathy (PML).

17 Jan 2005

Molecular pathway turns a juvenile heart into an adult heart

Researchers at the University of California, San Diego (UCSD) School of Medicine have discovered the molecular sequence of events in mice that turn a juvenile heart into an adult heart capable of responding to increased workloads.

17 Jan 2005

Human Genome Project may have made traditional race-based measurements of human differences obsolete

New and sophisticated methods for studying the relationship between human genetic differences, the environment, health and behavior, all made possible by the completion of the Human Genome Project, have made traditional race-based measurements of human differences obsolete

17 Jan 2005

FDA licenses Sanofi pasteur vaccine for protection against meningococcal disease

Sanofi pasteur, the vaccines business of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has licensed Menactra (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) for protection against meningococcal disease in adolescents and adults aged 11-55 years.

17 Jan 2005

Avastin available across Europe within the next few weeks

Roche has announced that the European Commission has approved Avastin (bevacizumab, rhuMAb-VEGF), the new innovative anti-angiogenesis drug, for the treatment of patients with previously untreated metastatic colorectal cancer.

16 Jan 2005

Sex hormones modulate brain damage in multiple sclerosis

Abnormalities in sex hormone levels may contribute to the damage to brain tissue typical of multiple sclerosis, indicates research in the Journal of Neurology Neurosurgery and Psychiatry.

16 Jan 2005

Discovery offers promise for treatment of age-related hearing loss

Researchers have discovered that deletion of a specific gene permits the proliferation of new hair cells in the cochlea of the inner ear -- a finding that offers promise for treatment of age-related hearing loss. This type of hearing loss is caused by aging, disease, certain drugs, and the cacophony of modern life. It is the most common cause of hearing loss in older people.

13 Jan 2005

Researchers shed new light on the development of cancers, particularly breast and prostate cancer

Researchers at Brown Medical School and Rhode Island Hospital have shed new light on the activation of a protein key to the development of cancers, particularly breast and prostate cancer, the most commonly diagnosed cancers in the United States.

13 Jan 2005

1 billion people with high blood pressure by 2025

The proportion of the world’s adult population with high blood pressure is predicted to increase from a quarter to a third by 2025, totalling over one billion, conclude authors of a study published in this week’s issue of The LANCET.

13 Jan 2005

Evaluation of BAY 43-9006 (Sorafenib) for pancreatic cancer

Oncologists from USC/Norris Comprehensive Cancer Center are running tests on a new pancreatic cancer drug that targets the cancer from two directions.

13 Jan 2005

Alternative therapies and conventional medical therapies should be held to same standards

Stating that health care should strive to be both comprehensive and evidence-based, a new report from the Institute of Medicine of the National Academies calls for conventional medical treatments and complementary and alternative treatments to be held to the same standards for demonstrating clinical effectiveness.

13 Jan 2005

Smoking marijuana is associated with increased risk of many of the same symptoms as smoking cigarettes

Smoking marijuana is associated with increased risk of many of the same symptoms as smoking cigarettes--chronic bronchitis, coughing on most days, phlegm production, shortness of breath, and wheezing, according to a Yale study published in the Journal of General Internal Medicine.

13 Jan 2005

Low carbohydrate diet may prevent Alzheimer's disease

Researchers found that a low carbohydrate diet that reduced total caloric intake by 30% prevented the development of a fundamental feature of Alzheimer's disease (AD) in mice genetically engineered to develop the disease. The diet eliminated amyloid plaque development, which is the underlying pathology in AD.

12 Jan 2005

New tool to assess the quality of home health care

University of Michigan researchers are part of a team that has developed a new tool to assess the quality of home health care, with the goal of improving care and providing meaningful feedback about the care.

12 Jan 2005

Gene transfer used to deliver antibodies to fight Anthrax

Using gene transfer technology, investigators were able to immunize mice against anthrax in just 12 hours, according to new research featured in the February 2005 issue of Molecular Therapy, the peer-reviewed scientific journal of the American Society of Gene Therapy (ASGT).

12 Jan 2005

Study identifies potentially valuable applications for new drug Nifrolidine

Along with aiding efforts to study addicted smokers, a new drug that attaches only to areas of the brain that have been implicated in nicotine addiction may help studies of people battling other disorders such as Alzheimer’s disease and schizophrenia.

12 Jan 2005

Steady points to need for more rigorous evaluation of complementary & alternative medicine use

In a comparison of complementary and alternative medicine (CAM) use by adults in 1997 and 2002, researchers from Harvard Medical School found more than one in three U.S. adults (36.5 and 35.0 percent, respectively) used at least one form of CAM.

12 Jan 2005